Title: Evaluation of Echocardiographic Profile in Chronic Kidney Disease in a Tertiary Centre Hospital

Authors: Dr Sumit, Dr Mridul Chaturvedi, Dr Kushal Pal Singh

 DOI: https://dx.doi.org/10.18535/jmscr/v7i6.108

Abstract

Chronic kidney disease affects almost all systems of the body and results in various abnormalities, leaving significant morbidity and mortality. The prevalence of CKD progresses through stages and it is well known that patients are more likely to die than to progress to end stage renal disease. Heart and kidney are inextricably linked in terms of hemodynamic and regulatory functions. 2 D echocardiography is a very helpful, inexpensive and non-invasive tool for detecting early cardiac dysfunction. In the present study cardiac profile of patients with chronic kidney disease with the help of echocardiography and to correlate the findings with the GFR.

Keywords: Echocardiography, chronic kidney disease, LVH.

References

  1. McCullough PA: Why is chronic kidney disease the “spoiler” for cardiovascular outcomes?. J Am CollCardiol 2003; 41:725.
  2. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am SocNephrol. 2003; 14: 1927-39
  3. Mukesh Laddha Vishal Sachdeva  PM Diggikar, PK Satpathy, AL Kakrani ,Echocardiographic Assessment of Cardiac Dysfunction in Patients of End Stage Renal Disease on Haemodialysis, Journal of the association of physicians of India January 2014 Vol. 62
  4. D'Cruz IA, Bhatt GR, Cohen HC, Glick G., Echocardiographic detection of cardiac involvement in patients with chronicrenal failure, Arch Intern Med. 1978 May;138(5):720-4.
  5. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003; 14: 159-68.
  6. Gansevoort RT, Correa- Rotter R, Hemmelgarn BR et al. Chronic kidney disease and cardiovascular risk: epidemiology mechanisms and prevention. Lancet 2013;382:339-52.
  7. Herzog CA, Asinger RW, Berger AK et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney Disease: improving Global Outcomes (KDIGO).Kidney int 2011;80:572-86.
  8. Levin A, Singer J, Thrompson CR, Ross H, Lewis M:Prevalant left ventricular hypertrophy in the predialysis population: Indentifying opportunities for intervention. Am J Kidney Dis 1996;27:3476-354.
  9. McGregor E,Jardine AG,Murray LS, Dargie HJ, Rodger RS ,Junor BJ, et al:Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998;13:1499-1505.
  10. Parfrey PS, Foley RN, Harnett JD,Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11:1277-1285
  11. Barberato SH, Pecoits Filho R:Prognostic value of left atrial volume index in hemodialysispatients. Arq Bras Cardiol 2—7;88:650.

Corresponding Author

Dr Mridul Chaturvedi

Professor P.G Dept. of Medicine, Agra (INDIA)